AnaptysBio, Inc. ANAB Balance Sheet Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| $248.47M+4.3% | $238.2M+117% | $109.83M+148% | $44.3M-55.1% | $98.64M-19.9% | ||
| $37.99M-48.3% | $73.44M-47.2% | $139.12M-37.2% | $221.41M-8.2% | $241.3M-8.0% | ||
| $25.75M-23.9% | $33.85M-55.3% | $75.69M+253% | $21.42M+19.8% | $17.88M-56.1% | ||
| $316.11M-9.7% | $350.25M+5.9% | $330.65M+13.3% | $291.91M-19.6% | $363.11M-15.9% | ||
| $1.28M-6.6% | $1.37M-8.7% | $1.5M-7.9% | $1.63M-6.5% | $1.74M-5.8% | ||
| $329.68M-9.5% | $364.4M+3.2% | $353.1M+5.3% | $335.25M-20.6% | $422.05M-12.8% | ||
| $7.52M+94.2% | $3.87M+33.8% | $2.89M-13.1% | $3.33M-45.6% | $6.12M+53.0% | ||
| $41.7M+8.0% | $38.63M+1.4% | $38.1M+7.3% | $35.53M-19.3% | $44.04M-3.1% | ||
| $29K+3.6% | $28K0.0% | $28K0.0% | $28K-6.7% | $30K0.0% | ||
| -$825.44M-6.8% | -$772.56M+6.0% | -$822.17M+1.8% | -$837.29M-4.8% | -$798.66M-5.2% | ||
| $12.75M-65.7% | $37.21M+226% | -$29.42M+34.2% | -$44.73M-231% | $34.02M-52.0% | ||
| $329.68M-9.5% | $364.4M+3.2% | $353.1M+5.3% | $335.25M-20.6% | $422.05M-12.8% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are AnaptysBio, Inc.'s total assets?
- AnaptysBio, Inc. (ANAB) holds $329.7M in total assets, down 21.9% year over year.
- How much debt does AnaptysBio, Inc. have?
- AnaptysBio, Inc. carries $13.6K in total debt against $12.7M of shareholders' equity, a debt-to-equity ratio of 0.00.
- How much cash does AnaptysBio, Inc. have?
- AnaptysBio, Inc. holds $248.5M in cash and equivalents.
- Can AnaptysBio, Inc. cover its short-term obligations?
- Its current ratio is 7.58 — current assets exceed current liabilities.
- Where does AnaptysBio, Inc.'s balance sheet data come from?
- Every line is extracted from AnaptysBio, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
